The Company’s R&D strengths are in developing intellectual property in non-infringing processes and resolving complex chemistry challenges. Mediqsane Healthcare is in the process of developing new drug delivery systems, new dosage formulations, and applying new technology for better processes.

The Centre focused on the areas of organic synthesis, analytical research, dosage form development, pharmacology, bio-equivalence studies and drug delivery systems.

The Company’s commitment towards developing innovative technologies and creating a knowledge base in chemical synthesis, high quality generic formulations and development of drug delivery systems.